Study of Different Doses of a Novel Treatment for Onychomycosis

NCT00679770 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Distal, Subungual Onychomycosis

Interventions

DRUG: AN2690, 2.5%
DRUG: AN2690, 5%
DRUG: AN2690, 7.5%
DRUG: Vehicle

Sponsor

Pfizer